Predicting melanoma risk: Theory, practice and future challenges

Melanoma Management

Volumn 1, Issue 2, 2014, Pages 105-114

  Whiteman, David ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Cancer control; Early detection; Melanoma; Prevention; Risk factors; Risk prediction; Risk stratification

Indexed keywords

CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CLINICAL PRACTICE; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HEALTH CARE PRACTICE; HUMAN; MELANOMA; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUN EXPOSURE; TREATMENT OUTCOME; ULTRAVIOLET RADIATION;

EID: 84978370058     PISSN: 20450885     EISSN: 20450893     Source Type: Journal    
DOI: 10.2217/MMT.14.15     Document Type: Review

References (52)

1. Australian Institute of Health and Welfare. Australian Cancer Incidence and Mortality Books. Australian Institute of Health and Welfare, Australia (2012).
2. SEER Cancer Statistics Review, 1975-2014. Howlader N, Noone AM, Krapcho M et al. (Eds). National Cancer Institute, MD, USA, (2013).
3. Erdmann F, Lortet-Tieulent J, Schüz J et al. International trends in the incidence of malignant melanoma 1953-2008 - are recent generations at higher or lower risk? Int. J. Cancer 132(2), 385-400 (2013).
4. Wallingford S, Alston R, Birch J, Green A. Increases in invasive melanoma in England, 1979-2006, by anatomical site. Br. J. Dermatol. 165(4), 859-864 (2011).
5. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ 338, b375 (2009).
6. Freedman AN, Seminara D, Gail MH et al. Cancer risk prediction models: a workshop on development, evaluation, and application. J. Natl Cancer Inst. 97(10), 715-723 (2005).
7. Gail MH, Brinton LA, Byar DP et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl Cancer Inst. 81(24), 1879-1886 (1989).
8. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann. Intern. Med. 139(12), 959-965 (2003).
9. Ohori M, Swindle P. Nomograms and instruments for the initial prostate evaluation: the ability to estimate the likelihood of identifying prostate cancer. Semin. Urol. Oncol. 20(2), 116-122 (2002).
10. Eastham JA, May R, Robertson JL, Sartor O, Kattan MW. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/ml. Urology 54(4), 709-713 (1999).
11. Spitz MR, Hong WK, Amos CI et al. A risk model for prediction of lung cancer. J. Natl Cancer Inst. 99(9), 715-726 (2007).
12. Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ 338, b604 (2009).
13. Marrett LD, King WD, Walter SD, From L. Use of host factors to identify people at high risk for cutaneous malignant melanoma. CMAJ 147(4), 445-453 (1992).
14. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet 2(8661), 487-490 (1989).
15. English DR, Armstrong BK. Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia. BMJ 296(6632), 1285-1288 (1988).
16. Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ 338, b605 (2009).
17. Wallis EJ, Ramsay LE, Haq IU et al. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffeld table in the 1995 Scottish Health Survey population. BMJ 320(7236), 671-676 (2000).
18. Jackson R. Guidelines on preventing cardiovascular disease in clinical practice: absolute risk rules - but raises the question of population screening. BMJ 320(7236), 659-661 (2000).
19. Isles CG, Ritchie LD, Murchie P, Norrie J. Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods. BMJ 320(7236), 690-691 (2000).
20. Vuong K, Mcgeechan K, Armstrong BK, Cust AE. Risk prediction models for incident primary cutaneous melanoma: a systematic review. JAMA Dermatol. 150(4), 434-444 (2014).
21. Stefanaki I, Panagiotou OA, Kodela E et al. Replication and predictive value of SNPs associated with melanoma and pigmentation traits in a southern European case-control study. PLoS ONE 8(2), e55712 (2013).
22. Quereux G, Moyse D, Lequeux Y et al. Development of an individual score for melanoma risk. Eur. J. Cancer Prev. 20(3), 217-224 (2011).
23. Fortes C, Mastroeni S, Bakos L et al. Identifying individuals at high risk of melanoma: a simple tool. Eur. J. Cancer Prev. 19(5), 393-400 (2010).
24. Fears TR, Guerry DT, Pfeiffer RM et al. Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J. Clin. Oncol. 24(22), 3590-3596 (2006).
25. Cho E, Rosner BA, Feskanich D, Colditz GA. Risk factors and individual probabilities of melanoma for whites. J. Clin. Oncol. 23(12), 2669-2675 (2005).
26. Guther S, Ramrath K, Dyall-Smith D, Landthaler M, Stolz W Development of a targeted risk-group model for skin cancer screening based on more than 100,000 total skin examinations. J. Eur. Acad. Dermatol. Venereol. 26(1), 86-94 (2012).
27. Harbauer A, Binder M, Pehamberger H, Wolff K, Kittler H. Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk. Melanoma Res. 13(5), 537-542 (2003).
28. Williams LH, Shors AR, Barlow WE, Solomon C, White E. Identifying persons at highest risk of melanoma using self-assessed risk factors. J. Clin. Exp. Dermatol. Res. 2(6), 1000129 (2011).
29. Mar V, Wolfe R, Kelly JW. Predicting melanoma risk for the Australian population. Australas. J. Dermatol. 52(2), 109-116 (2011).
30. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. Your Disease Risk. www.yourdiseaserisk.wustl.edu
31. Norwest Skin Cancer Centre. Skin Cancer Risk Calculator. www.skincancerclinics.net.au
32. Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005. J. Am. Acad. Dermatol. 57(1), 60-66 (2007).
33. English DR, Armstrong BK, Kricker A. Reproducibility of reported measurements of sun exposure in a case-control study. Cancer Epidemiol. Biomarkers Prev. 7(10), 857-863 (1998).
34. Morze CJ, Olsen CM, Perry SL et al. Good test-retest reproducibility for an instrument to capture self-reported melanoma risk factors. J. Clin. Epidemiol. 65(12), 1329-1336 (2012).
35. Kraft P, Hunter DJ. Genetic risk prediction - are we there yet? N. Engl. J. Med. 360 (17), 1701-1703 (2009).
36. Williams PF, Olsen CM, Hayward NK, Whiteman DC. Melanocortin 1 receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden. Int. J. Cancer 129 (7), 1730-1740 (2011).
37. Dwyer T, Stankovich JM, Blizzard L et al. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? Am. J. Epidemiol. 159(9), 826-833 (2004).
38. Olsen CM, Green AC, Neale RE et al. Cohort profle: the QSkin sun and health study. Int. J. Epidemiol. 41(4), 929-929i (2012).
39. Kvaskoff M, Mesrine S, Clavel-Chapelon F, Boutron-Ruault M-C. Endometriosis risk in relation to naevi, freckles and skin sensitivity to sun exposure: the French E3N cohort. Int. J. Epidemiol. 38 (4), 1143-1153 (2009).
40. Veierød MB, Weiderpass E, Thörn M et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J. Natl Cancer Inst. 95(20), 1530-1538 (2003).
41. Position Statement: Screening and Early Detection of Skin Cancer. Cancer Council Australia. Australia (2007).
42. Moyer VA; U.S. Preventive Services Task Force. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 150(3), 188-193 (2009).
43. Marsden J, Newton-Bishop J, Burrows L et al. Revised UK guidelines for the management of cutaneous melanoma 2010. Br. J. Dermatol. 163(2), 238-256 (2010).
44. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group, New Zealand (2008).
45. Smith L, Qian M, Ng E et al. Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure. J. Clin. Oncol. 30 (15S), 74 (2012).
46. Whiteman DC, Green AC. A risk prediction tool for melanoma? Cancer Epidemiol. Biomarkers Prev. 14(4), 761-763 (2005).
47. Fargnoli MC, Piccolo D, Altobelli E, Formicone F, Chimenti S, Peris K. Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case-control study. Melanoma Res. 14(2), 151-157 (2004).
48. Landi M, Baccarelli A, Calista D et al. Combined risk factors for melanoma in a Mediterranean population. Br. J. Cancer 85(9), 1304-1310 (2001).
49. Barbini P, Cevenini G, Rubegni P et al. Instrumental measurement of skin colour and skin type as risk factors for melanoma: a statistical classification procedure. Melanoma Res. 8(5), 439-447 (1998).
50. Garbe C, Buttner P, Weiss J et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J. Invest. Dermatol. 102(5), 695-699 (1994).
51. National Cancer Institute. Melanoma Risk Assessment Tool. www.cancer.gov/melanomarisktool
52. Victorian Melanoma Service. Emily's Melanoma Risk Calculator. http://victorianmelanomaservice.org